Targeted iron oxide nanoparticles for the enhancement of radiation therapy
نویسندگان
چکیده
منابع مشابه
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Magnetic iron oxide (IO) nanoparticles with a long blood retention time, biodegradability and low toxicity have emerged as one of the primary nanomaterials for biomedical applications in vitro and in vivo. IO nanoparticles have a large surface area and can be engineered to provide a large number of functional groups for cross-linking to tumor-targeting ligands such as monoclonal antibodies, pep...
متن کاملGel dosimetry: The effect of gold nanoparticles on the dose enhancement in the external radiation therapy
Background: Normoxic type MAGICA gel dosimeters are established for dose quantification in three dimensions for radiotherapy. Objective(s): The ability of MAGICA polymer gel was assessed by experimental measurements method for studying the effect of gold nanoparticles (GNPs) in dose enhancement under the external 18MV radiotherapy practices. <...
متن کاملTargeted MRI for Breast Cancer using Iron Oxide Nanoparticles
Magnetic Resonance Imaging (MRI) utilizes a powerful magnetic field to align the nuclear magnetization of hydrogen atoms in water in the body without the use of ionizing radiation. Iron oxide (IO) nanoparticles are the only FDA approved nanoparticles used as a MRI contrast agent. Paramagnetic IO nanoparticles can induce remarkably strong magnetic resonance imaging contrast and have a large surf...
متن کاملThe Use of Iron Oxide Nanoparticles for Pancreatic Cancer Therapy
malignant stages, making curative therapy impossible and leading to poor prognosis and incidence equalling mortality [8]. In the year 2000, there were 217,000 new cases of pancreatic cancer with 213,000 deaths worldwide, while in Europe there were 60,139 new patients with 64,801 deaths [9]. In the UK, 7,152 new cases were seen with 7,250 deaths as a result of PDAC [10]. PDAC affects more wester...
متن کاملDevelopment and Characterization of Targeted Iron Oxide Nanoparticles for Pancreatic Tumor Therapy
The challenge of specificity remains a great obstacle in modern cancer therapeutics. Pancreatic cancer patients, with a survival rate of less than 5%, are particularly reliant on the specificity of drug therapies due to late diagnosis and non-resectable tumors. This study investigates the targeting of an iron oxide nanovehicle with the novel monoclonal antibody, CHO31.1, to the surface antigen ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomaterials
سال: 2016
ISSN: 0142-9612
DOI: 10.1016/j.biomaterials.2016.07.032